Matthias Stoelzel

Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder ( <scp>SYNERGY</scp> study)

Christopher R. Chapple, Paul Abrams, Salvador Arlandis et al. · British Journal of Urology · 2017 · 174 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Source apportionment of ambient particles: Comparison of positive matrix factorization analysis applied to particle size distribution and chemical composition data

Jianwei Gu, Mike Pitz, Jürgen Schnelle‐Kreis et al. · Atmospheric Environment · 2011 · 139 citations

Natural Sciences, Chemistry, Environmental Sciences +17

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Christian Gratzke, Rob van Maanen, Christopher R. Chapple et al. · European Urology · 2018 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

Christopher R. Chapple, Francisco Cruz, Linda Cardozo et al. · European Urology · 2019 · 73 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Patient‐reported outcomes from SYNERGY, a randomized, double‐blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients

Dudley Robinson, Con Kelleher, David Staskin et al. · Neurourology and Urodynamics · 2017 · 37 citations

Medicine, Pharmacology, Pharmacotherapy +17